tirzepatide tracker app Glapp Shotsy - GLP-1 Tracker -
Description
It is not known if Zepbound will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
It does not change the volume per dose
Note: If you see any discoloration or if the liquid remains cloudy after several minutes of resting, this may indicate a problem with the medication or the reconstitution process
On April 30, 2026, the FDA proposed permanently excluding tirzepatide (along with semaglutide and liraglutide) from the 503B Bulks List, finding no clinical need basis
For now, we will have to take it by injection once a week
If you inject Monday morning one week and Monday evening the next, it will not affect results
